Table 6.

Sensitivity Test Based on Intent‐to‐Treat Approach

	Apixaban vs Warfarin (n=15 390)	Dabigatran vs Warfarin (n=28 614)	Rivaroxaban vs Warfarin (n=32 350)
Stroke or systemic embolism	0.72a (0.55–0.95)	1.01 (0.87–1.16)	1.04 (0.89–1.21)
Ischemic stroke	0.73a (0.53–1.00)	1.10 (0.94–1.30)	1.14 (0.95–1.37)
Hemorrhagic stroke	0.69 (0.36–1.32)	0.61b (0.42–0.87)	0.63a (0.43–0.91)

^a P<0.05.

^b P<0.01.